Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Receives Consensus Rating of "Hold" From Analysts
Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Receives Consensus Rating of "Hold" From Analysts
Shares of Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC – Get Rating) have been assigned an average recommendation of "Hold" from the six brokerages that are currently covering the firm, Marketbeat reports. Five research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12 month price target among brokerages that have covered the stock in the last year is $8.10.
據Marketbeat報道,目前報道Tabula Rasa Healthcare,Inc.(納斯達克代碼:TRHC-GET Rating)的六家券商給出了該公司股票的平均建議為持有。五位研究分析師對該股的評級為持有,一位分析師對該公司的評級為買入。在過去一年追蹤該股的券商中,12個月的平均目標價為8.10美元。
Several research firms recently weighed in on TRHC. StockNews.com upgraded Tabula Rasa HealthCare from a "sell" rating to a "hold" rating in a research report on Thursday, October 20th. Piper Sandler lowered their price objective on Tabula Rasa HealthCare from $6.00 to $4.00 and set a "neutral" rating on the stock in a research report on Monday, November 7th.
幾家研究公司最近對TRHC進行了權衡。在10月20日週四發佈的一份研究報告中,StockNews.com將Tabula Rasa Healthcare的評級從“賣出”上調至“持有”。派珀·桑德勒在11月7日週一的一份研究報告中將Tabula Rasa Healthcare的目標價從6.00美元下調至4.00美元,並將該股的評級定為“中性”。
Insider Buying and Selling
內幕買賣
In other news, CFO Thomas Cancro bought 11,500 shares of the firm's stock in a transaction that occurred on Monday, December 12th. The shares were bought at an average cost of $4.34 per share, for a total transaction of $49,910.00. Following the completion of the transaction, the chief financial officer now owns 211,500 shares of the company's stock, valued at $917,910. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Michael J. Purcell sold 10,000 shares of the business's stock in a transaction dated Friday, December 9th. The stock was sold at an average price of $4.26, for a total value of $42,600.00. Following the sale, the director now directly owns 88,514 shares in the company, valued at $377,069.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Thomas Cancro bought 11,500 shares of the firm's stock in a transaction that occurred on Monday, December 12th. The stock was purchased at an average price of $4.34 per share, for a total transaction of $49,910.00. Following the completion of the transaction, the chief financial officer now directly owns 211,500 shares of the company's stock, valued at approximately $917,910. The disclosure for this purchase can be found here. 7.25% of the stock is owned by company insiders.
在其他新聞方面,首席財務官託馬斯·坎克羅在12月12日星期一的一筆交易中購買了11,500股該公司的股票。這些股票是以每股4.34美元的平均成本購買的,總交易額為49,910.00美元。交易完成後,首席財務官現在擁有該公司211,500股股票,價值917,910美元。此次收購是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過此超鏈接。在相關新聞中,董事邁克爾·J·珀塞爾在一筆日期為12月9日(星期五)的交易中出售了10,000股該公司股票。這隻股票的平均售價為4.26美元,總價值為42,600.00美元。交易完成後,董事現在直接持有該公司88,514股股份,價值377,069.64美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過這個環節。此外,首席財務官託馬斯·坎克羅在12月12日星期一的一次交易中購買了11,500股該公司的股票。股票是以每股4.34美元的平均價格購買的,總交易額為49,910.00美元。交易完成後,首席財務官現在直接擁有公司股票211,500股,價值約917,910美元。關於這次購買的披露可以找到這裏。7.25%的股份由公司內部人士持有。
Institutional Investors Weigh In On Tabula Rasa HealthCare
機構投資者參與Tabula Rasa醫療保健
Tabula Rasa HealthCare Stock Performance
Tabula Rasa醫療保健類股表現
NASDAQ TRHC opened at $6.33 on Wednesday. The company has a market capitalization of $171.69 million, a PE ratio of -1.09 and a beta of 1.58. The business's fifty day moving average is $4.60 and its 200 day moving average is $4.38. Tabula Rasa HealthCare has a fifty-two week low of $2.09 and a fifty-two week high of $13.07.
納斯達克TRHC週三開盤報6.33美元。該公司市值為1.7169億美元,市盈率為-1.09,貝塔係數為1.58。該業務的50日移動均線切入位為4.60美元,200日移動均線切入位為4.38美元。Tabula Rasa Healthcare的52周低點為2.09美元,52周高位為13.07美元。
Tabula Rasa HealthCare (NASDAQ:TRHC – Get Rating) last released its earnings results on Thursday, November 3rd. The company reported ($0.94) earnings per share for the quarter, missing the consensus estimate of ($0.16) by ($0.78). The company had revenue of $77.10 million for the quarter, compared to analysts' expectations of $73.68 million. Tabula Rasa HealthCare had a negative net margin of 46.03% and a negative return on equity of 472.90%. On average, sell-side analysts forecast that Tabula Rasa HealthCare will post -2.11 EPS for the current year.
Tabula Rasa Healthcare(納斯達克代碼:TRHC-GET Rating)最近一次發佈財報是在11月3日(週四)。該公司公佈了本季度每股收益(0.94美元),低於普遍預期的(0.16美元)和(0.78美元)。該公司當季營收為7,710萬美元,高於分析師預期的7,368萬美元。Tabula Rasa Healthcare的淨利潤率為負46.03%,淨資產回報率為負472.90%。賣方分析師平均預測,Tabula Rasa Healthcare本年度每股收益將達到2.11美元。
Tabula Rasa HealthCare Company Profile
Tabula Rasa醫療保健公司簡介
(Get Rating)
(獲取評級)
Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems.
Tabula Rasa Healthcare,Inc.在美國作為一家醫療技術公司運營。該公司在兩個細分市場運營,CareVention Healthcare和MedWise Healthcare。它提供了EireneRx,一個基於雲的藥物決策支持和電子處方平臺,用於訪問患者的藥物相關信息;以及MedWise藥物治療管理軟件,一個基於雲的平臺,旨在幫助識別和解決藥物和健康相關問題。
Recommended Stories
推薦故事
- Get a free copy of the StockNews.com research report on Tabula Rasa HealthCare (TRHC)
- When Will Crane Holdings Take Flight?
- Is It Time To Get Aggressive With Defense Stocks?
- 3 Retail Stocks Ringing the Register in 2023
- Qualcomm Gets a Boost from Analysts, but is it Time to Buy?
- EVgo Stock is Charged Up to Ride the EV Adoption Wave
- 免費獲取StockNews.com關於Tabula Rasa Healthcare(TRHC)的研究報告
- Crane Holdings什麼時候起飛?
- 現在是時候積極投資國防類股了嗎?
- 2023年響亮登場的3只零售股
- 高通從分析師那裏得到了提振,但現在是收購的時候了嗎?
- EVGO股票充值,駕馭電動汽車普及浪潮
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.
接受Tabula Rasa Healthcare Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Tabula Rasa醫療保健和相關公司的最新新聞和分析師評級的每日簡明摘要。